investiledysfunction

Today, an article authored by Kenneth Klee was featured on TheDeal.com entitled “Better scorekeeping for investments in organic growth“ and highlighted comments by yours truly and Brilliont about the beneficial impact on organic growth that a corporate portfolio management discipline can enable. 

It’s interesting and actually quite progressive on the part of TheDeal.com to feature an article about organic growth as most of their readership are focused on deals, e.g., M&A - bankers and corporate development people within organizations.  And to some extent, organic growth and M&A are competitive levers that an organization can employ to grow.  Obviously, all organizations invest in organic growth (lowering attrition, acquiring new customers, selling more to existing customers) and many do evaluate and do M&A deals, but the two strategies can compete for resources and mindshare, e.g., build decisions (organic growth/corporate portfolio management) vs buy decisions (inorganic growth/corporate development). 

If you want to read the article, please click here.

We launched a site today called Investile Dysfunction which details the problems organizations face in getting their performance up. It mainly comes down to their inability to select the best projects and investments to maximize strategic and financial performance.

Investile dysfunction impairs most organization’s performance. The great news, however, is that it is 100% treatable and that treatment options are 100% safe. We’re glad to launch on April 1. Because it is time the foolishness by which organizations manage their resource allocation needs to be stopped.

You can end Investile Dysfunction. Help is available.